SCHEMBL5079833

SCHEMBL5079833

O=[N+]1C=CCc2ccccc2O1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8205757 0.98 MAOA (0.33) MAOAMAOB
Hydrochloric Acid SCHEMBL8209470 0.98 MAOA (0.33) MAOAMAOB
SCHEMBL3990102 0.77 MAOA (0.34) MAOAMAOB
SCHEMBL4728144 0.70 MAOA (0.42) MAOAMAOB
SCHEMBL3553901 0.67 MAOB (0.39) MAOAMAOB
SCHEMBL2461757 0.65 HTR6 (0.33)
SCHEMBL29434883 0.64 MAOA (0.41) MAOAMAOB
SCHEMBL7197365 0.64 MAOA (0.41) MAOAMAOB
SCHEMBL9209 0.64 MAOA (0.41) MAOAMAOB
SCHEMBL1420110 0.64 MAOA (0.41) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995021834-A1 OPTICALLY ACTIVE 4,1-BENZOXAZEPINE DERIVATIVES USEFUL AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-08-17 WO claimed
EP-1962832-A2 COMBINATIONS OF A QUALENE SYNTHASE INHIBITOR AND A HMG-COA REDUCTASE INHIBITOR FOR TREATING HYPERLIPIDEMIA Takeda Pharmaceutical Company Limited (JP) 2008-09-03 EP disclosed
EP-1776096-A2 CRP LOWERING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-04-25 EP disclosed
WO-2006129859-A2 COMBINATIONS OF A SQUALENE SYNTHASE INHIBITOR AND A HMG-COA REDUCTASE INHIBITOR FOR TREATING HYPERLIPIDEMIA TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-12-07 WO disclosed
WO-2006016681-A2 CRP LOWERING AGENT TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-02-16 WO disclosed
EP-1044190-B1 SYNTHESIS OF 11-ARYL-5,6-DIHYDRO-11H-DIBENZ(B,E)AZEPINES JOHNSON MATTHEY PHARMACEUTICAL (US) 2005-02-02 EP disclosed
EP-1009742-A1 5,5-DISUBSTITUTED-1,5-DIHYDRO-4,1-BENZOXAZEPIN-2(3H)-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-06-21 EP disclosed
EP-0979227-A1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS Takeda Chemical Industries, Ltd. (JP) 2000-02-16 EP disclosed
WO-1999011635-A1 5,5-DISUBSTITUTED-1,5-DIHYDRO-4,1-BENZOXAZEPIN-2(3H)-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-03-11 WO disclosed
WO-1998047882-A1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-29 WO disclosed
EP-0862562-A1 BENZOXAZEPINE COMPOUNDS, THEIR PRODUCTION AND USE AS LIPID LOWERING AGENTS Takeda Chemical Industries, Ltd. (JP) 1998-09-09 EP disclosed
US-5677298-A USEFUL FOR THE PROPHYLAXIS OR THERAPY OF HYPERCHOLESTEREMIA OR CORONOARY SCLEROSIS OF MAMMALS TAKEDA CHEMICAL INDUSTRIES (JP) 1997-10-14 US disclosed
WO-1997010224-A1 BENZOXAZEPINE COMPOUNDS, THEIR PRODUCTION AND USE AS LIPID LOWERING AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-03-20 WO disclosed